Crystal structures and other biochemical data indicate that the N-terminal cap (NCap) region of the Abelson tyrosine kinase (c-Abl) is important for maintaining the downregulated conformation of the kinase domain. The exact contributions that NCap makes in stabilizing the various intramolecular interactions within c-Abl are less clear. While the NCap appears important for locking the SH3/SH2 domains to the back of the kinase domain, there may be other more subtle elements of regulation. Hydrogen exchange (HX) and mass spectrometry (MS) were used to determine if the NCap contributes to intramolecular interactions involving the Abl SH3 domain. Under physiological conditions, the Abl SH3 domain underwent partial unfolding and its unfolding half-life was slowed during binding to the SH2-kinase linker, providing a unique assay to test NCap-induced stabilization of the SH3 domain in various constructs. The results showed that NCap stabilizes the dynamics of the SH3 domain in certain constructs but does not increase the relative affinity of the SH3 domain for the native SH2-kinase linker. The stabilization effect was absent in constructs of just NCap + SH3 but was obvious when the SH2 domain and the SH2-kinase linker were present. These results suggest that interactions between NCap and the SH3 domain can contribute to c-Abl stabilization in constructs that contain at least the SH2 domain, an effect that may partially compensate for the absence of the negative regulatory C-terminal tail found in the related Src family of kinases.The Abelson protein-tyrosine kinase (c-Abl) is a non-receptor tyrosine kinase ubiquitously expressed and highly conserved in metazoan evolution. c-Abl has many cellular functions including regulation of cell growth, survival, and differentiation, oxidative stress and DNAdamage responses, actin dynamics, and cell adhesion and migration (1,2). Fusion of the gene encoding c-Abl on chromosome 9 with the breakpoint cluster region (Bcr) gene on chromosome 22 results in the formation of a fusion protein, Bcr-Abl, which has constitutive protein-tyrosine kinase activity (3,4). The enhanced tyrosine kinase activity of the Bcr-Abl protein contributes to several disease states including chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) (4). However regulation of both c-Abl and the BcrAbl fusion protein is still not well understood.The tyrosine kinase core of c-Abl is composed of a number of regions including an N-terminal cap (NCap) region, an SH3 domain, an SH2 domain, and a kinase domain (see Fig. 1A). Multiple intramolecular interactions involving these regions occur in c-Abl and these interactions are crucial for maintaining the downregulated state (5). Although the c-Abl core is very similar to Src-family tyrosine kinases (SFKs) in structure (1,6,7), significant differences † We are pleased to acknowledge generous financial support from the NIH: GM070590 (to J.R.E.) and CA101828 (to T.E.S.) *Address correspondence: John R. Engen 341 Mugar Life Sciences, The Barnett Instit...